Total Payments
$963,549
2024 Payments
$109,031
Companies
54
Transactions
3,013
Medicare Patients
10,343
Medicare Billing
$9.4M
Payment Breakdown by Category
Other$691,235 (71.7%)
Consulting$111,261 (11.5%)
Travel$106,190 (11.0%)
Food & Beverage$54,350 (5.6%)
Education$512.95 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $663,538 | 406 | 68.9% |
| Consulting Fee | $111,261 | 44 | 11.5% |
| Travel and Lodging | $106,190 | 434 | 11.0% |
| Food and Beverage | $54,350 | 2,096 | 5.6% |
| Honoraria | $27,697 | 18 | 2.9% |
| Education | $512.95 | 14 | 0.1% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
General
$963,549
3,012 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $311,608 | 598 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $139,194 | 132 | $0 (2023) |
| UCB, Inc. | $118,204 | 329 | $0 (2024) |
| Radius Health, Inc. | $94,133 | 166 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $67,368 | 296 | $0 (2024) |
| Janssen Biotech, Inc. | $65,422 | 176 | $0 (2024) |
| ABBVIE INC. | $60,317 | 233 | $0 (2024) |
| Lilly USA, LLC | $36,462 | 155 | $0 (2024) |
| Horizon Therapeutics plc | $15,417 | 113 | $0 (2023) |
| Celgene Corporation | $14,816 | 59 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $109,031 | 381 | Amgen Inc. ($34,303) |
| 2023 | $103,687 | 322 | ABBVIE INC. ($29,475) |
| 2022 | $116,135 | 360 | Janssen Scientific Affairs, LLC ($42,026) |
| 2021 | $66,207 | 228 | Janssen Scientific Affairs, LLC ($19,531) |
| 2020 | $68,384 | 149 | Janssen Scientific Affairs, LLC ($16,778) |
| 2019 | $201,720 | 572 | Amgen Inc. ($95,800) |
| 2018 | $182,155 | 585 | Amgen Inc. ($56,467) |
| 2017 | $116,231 | 416 | Amgen Inc. ($58,298) |
All Payment Transactions
3,013 individual payment records from CMS Open Payments — Page 1 of 121
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $550.50 | General |
| Category: Bone Health | ||||||
| 12/24/2024 | Fresenius Kabi USA, LLC | — | Food and Beverage | In-kind items and services | $17.06 | General |
| 12/19/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Endocrinology | ||||||
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $27.79 | General |
| Category: Immunology | ||||||
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $1.90 | General |
| Category: Immunology | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $1.34 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Immunology | ||||||
| 12/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $2.04 | General |
| Category: Immunology | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $34.54 | General |
| Category: Immunology | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.60 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $1.23 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/09/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $10.26 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/08/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $1.77 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/07/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,475.00 | General |
| Category: Immunology | ||||||
| 12/07/2024 | Radius Health, Inc. | Tymlos (Drug) | Consulting Fee | Cash or cash equivalent | $270.00 | General |
| Category: Endocrinology | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), HUMIRA | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Travel and Lodging | In-kind items and services | $583.58 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $29.27 | General |
| Category: Bone Health | ||||||
| 12/02/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/01/2024 | Radius Health, Inc. | Tymlos (Drug) | Consulting Fee | Cash or cash equivalent | $1,080.00 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 2,516 | 193,314 | $4.5M | $2.3M |
| 2022 | 33 | 2,863 | 174,869 | $4.3M | $2.2M |
| 2021 | 32 | 2,436 | 174,364 | $4.2M | $2.3M |
| 2020 | 30 | 2,528 | 172,799 | $4.4M | $2.5M |
Total Patients
10,343
Total Services
715,346
Medicare Billing
$9.4M
Procedure Codes
127
All Medicare Procedures & Services
127 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 361 | 27,782 | $775,260 | $512,347 | 66.1% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 67 | 49,980 | $649,740 | $396,561 | 61.0% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 38 | 10,400 | $644,800 | $350,005 | 54.3% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 26 | 47,432 | $450,395 | $222,529 | 49.4% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 32 | 19,950 | $698,250 | $209,565 | 30.0% |
| J9312 | Injection, rituximab, 10 mg | Office | 2023 | 14 | 2,351 | $258,500 | $149,154 | 57.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 616 | 1,497 | $232,020 | $144,831 | 62.4% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 24 | 27,600 | $372,600 | $107,807 | 28.9% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 14 | 2,031 | $115,710 | $53,239 | 46.0% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 441 | 863 | $81,985 | $50,927 | 62.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 124 | 441 | $88,200 | $46,629 | 52.9% |
| J7322 | Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | Office | 2023 | 15 | 1,536 | $56,003 | $20,531 | 36.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 101 | 101 | $21,210 | $11,800 | 55.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 73 | 187 | $20,383 | $8,355 | 41.0% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 24 | 106 | $9,010 | $2,435 | 27.0% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 133 | 417 | $4,170 | $2,066 | 49.5% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 43 | 51 | $4,284 | $2,013 | 47.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 31 | $3,410 | $1,927 | 56.5% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 32 | 57 | $3,420 | $1,703 | 49.8% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 50 | 51 | $3,468 | $1,381 | 39.8% |
| 20600 | Aspiration and/or injection of fluid from small joint | Office | 2023 | 22 | 34 | $2,822 | $1,104 | 39.1% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 34 | 45 | $2,925 | $1,072 | 36.7% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2023 | 20 | 38 | $2,546 | $979.39 | 38.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 18 | 18 | $1,800 | $915.43 | 50.9% |
| 20551 | Injection into tendon at attachment to bone or muscle | Office | 2023 | 13 | 16 | $1,424 | $704.98 | 49.5% |
About Dr. Jonathan Greer, M.D
Dr. Jonathan Greer, M.D is a Rheumatology healthcare provider based in Boynton Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1003816281.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Greer, M.D has received a total of $963,549 in payments from pharmaceutical and medical device companies, with $109,031 received in 2024. These payments were reported across 3,013 transactions from 54 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($663,538).
As a Medicare-enrolled provider, Greer has provided services to 10,343 Medicare beneficiaries, totaling 715,346 services with total Medicare billing of $9.4M. Data is available for 4 years (2020–2023), covering 127 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Boynton Beach, FL
- Active Since 07/28/2005
- Last Updated 01/31/2019
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1003816281
Products in Payments
- Prolia (Biological) $175,443
- Cimzia (Drug) $106,655
- EVENITY (Biological) $104,348
- TREMFYA (Drug) $84,324
- Tymlos (Biological) $69,333
- COSENTYX (Biological) $62,069
- STELARA (Biological) $61,392
- SIMPONI ARIA (Biological) $56,771
- RINVOQ (Biological) $38,720
- TALTZ (Drug) $32,274
- Tymlos (Drug) $24,530
- SKYRIZI (Biological) $20,228
- Otezla (Drug) $14,901
- PENNSAID (Drug) $11,689
- LYRICA (Drug) $10,547
- Bimzelx (Biological) $10,269
- KEVZARA (Drug) $7,346
- NEUTRASAL (Drug) $3,970
- KRYSTEXXA (Biological) $3,658
- Tremfya (Drug) $2,113
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Boynton Beach
Dr. Amiel Tokayer, M.d, M.D
Rheumatology — Payments: $69,482
Rheumatology $69,482
Dr. Kenneth Bresky, D.o, D.O
Rheumatology — Payments: $38,173
Rheumatology $38,173
Dr. Catherine Garcia, M.d, M.D
Rheumatology — Payments: $28,404
Rheumatology $28,404
Dr. Maricarmen Quintero, M.d, M.D
Rheumatology — Payments: $14,524
Rheumatology $14,524
Maria Aldahan
Rheumatology — Payments: $1,004
Rheumatology $1,004
Dr. Michael Ross, M.d, M.D
Rheumatology — Payments: $391.89
Rheumatology $391.89